• Skip to main content

Aphios

Inspired by Nature, Enabled by Science®

  • Products
    ▼
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      ▼
      • Oncology
        ▼
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        ▼
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          ▼
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        ▼
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        ▼
        • APH-0907
    • Research Chemicals & APIs
      ▼
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    ▼
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      ▼
      • CFN
      • PNS
      • PNP
    • Drug Safety
      ▼
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      ▼
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      ▼
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    ▼
    • Investors Overview
      ▼
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    ▼
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop
  • Products
    • Enhanced Therapeutic Products Overview
    • Therapeutic Products Pipeline
      • Oncology
        • Zindol®: Ginger Extract Therapy for CINV
        • APH-0701
        • APH-0911
        • APH-0912
        • APH-0804
        • Taxosomes™
        • Camposomes™
        • Dermos™
        • APH-0201
        • Sperol™
      • Infectious Disease
        • APH-0812
        • APH-0202
        • nanoHYP™
        • Asterias™
        • Marinus™
        • HIV/AIDS Therapeutic Vaccine
        • Anti-HIV Therapeutics
        • Anti-Influenza Therapeutics
        • Vaccine Adjuvant Technology
          • Anthrax Vaccine Adjuvant
      • CNS Disorders
        • APH-1104
        • Xantol™
        • APH-1501: CBD + LDN Nanotherapy for OUD
        • APH-1502: CBD Nanotherapy for CIPNP
        • APH-1503: CBD Nanotherapy for Anxiety Relief
        • APH-1504: CBD Nanotherapy for Multiple Sclerosis
        • APH-1505: CBD Nanotherapy for Epilepsy
        • APH-0802 – nanoTHC™
        • APH-1403
      • Diabetes
        • APH-0907
    • Research Chemicals & APIs
      • Adhyperforin
      • Adhyperforin DCHA
      • Betulin
      • Betulinic Acid
      • Bryostatin 1
      • Bryostatin 2
      • Bryostatin 3
      • Camptothecin
      • C-ATR
      • Cephalomannine: Anti-Tumor Taxane Compound from Yew Tree
      • Cyclopamine: Steroidal Alkaloid Hedgehog Pathway Inhibitor from Corn Lily
      • Cycloposine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • 10-DAB
      • 9-DHAB
      • Δ9-THC
      • Δ9-THCA
      • Frondoside A
      • 6-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 8-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • 10-Gingerol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Hypericin: Photodynamic Antiviral Compound from St. John’s Wort (Hypericum perforatum)
      • Hyperforin
      • Hyperforin DCHA
      • Jervine: Steroidal Alkaloid Hedgehog Pathway Antagonist from Corn Lily (Veratrum californicum)
      • MLA
      • Muldamine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
      • Nobiletin: Polymethoxylated Flavone from Citrus Peel (Citrus sinensis)
      • Paclitaxel: Natural Anti-Mitotic Anticancer Compound from Yew (Taxus sp.)
      • Phloridzin Dihydrate: Dihydrochalcone SGLT Inhibitor from Apple Wood (Malus sp.)
      • Sclareolide: Sesquiterpene Lactone from Clary Sage (Salvia sclarea)
      • 6-Shogaol: Bioactive Compound from Ginger Root (Zingiber officinale)
      • Tangeretin: Bioflavonoid from Citrus Peel (Citrus sinensis)
      • Veratramine: Steroidal Alkaloid from Corn Lily (Veratrum californicum)
    • Equipment
    • Quality of Life Medicines
  • Technology
    • Enabling Technology Platforms
    • Drug Discovery
    • Drug Manufacturing
    • Drug Delivery
      • CFN
      • PNS
      • PNP
    • Drug Safety
      • CFI™ Mechanisms of Action & Applications
    • Microbial Cell Disruption
    • Crystallization
      • Natural Therapeutics Crystallization – CRY
      • SuperFluids Crystallization Process
    • Biomass Pretreatment
      • Cellulosic Biomass Pretreatment (CBP) – Aosic Platform
  • Investors
    • Investors Overview
      • Aphios Pharma LLC
      • Aphios International LLC
      • Zindol LLC
  • About
    • Company Overview
    • Management
    • Directors
    • Scientific Advisors
    • Community Involvement
    • Press Releases
    • Events
    • Careers
  • Contact
  • Shop

Press Releases

← Back to Press Releases

Aphios Granted Japanese Patent for Novel Bryostatins To Treat Alzheimer’s And Other Diseases

Woburn, Mass. – May 13, 2019 − Aphios Corporation today announced that it has been granted Japanese Patent No. 2015-545195 by the Japan Patent Office. The patent, entitled “Bryoid Compositions, Methods of Making and Use Thereof,” is for the composition of matter of novel Bryostatins, methods of manufacturing, and use in the treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson, Down’s syndrome, Hutchinson, Multiple Sclerosis and other spongiform encephalopathies; virus latency diseases such as HIV and Herpes; cancer; and amyloid mediated diseases such as glaucoma.

Bryoids consist of a family of Bryostatins, such as Bryostatin-1, that are complex cyclic macrolide molecules. Bryoids were originally isolated from the marine bryozoan, Bugula neritina, in small quantities. Methods of synthesis are complex and costly. Twenty-one Bryoid compositions, known as Bryostatins and numbered 1-21, have been identified. Many of the Bryoids are known to possess anticancer activities.

According to Dr. Trevor P. Castor, President and CEO, Aphios Corporation, and inventor of this patent: “These new Bryoids, Bryostatin-22 and Bryostatin-23, are highly potent nanomolar activators of a-secretase activity in neuroblastoma cell models, being more effective than Bryostatin-1 at increasing activity of all protein kinase C (PKC) isoforms, particularly the novel PKC isoforms, delta and epsilon. Aphios is developing these compounds for Alzheimer’s Disease, HIV-1 latency and Multiple Sclerosis, and is seeking collaborative research partners.”

About Aphios Corporation: Aphios Corporation (www.aphios.com) is a clinical stage, biotechnology company developing green enabling technology platforms for improving drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Based on these platforms, Aphios is developing enhanced therapeutics for health maintenance and disease prevention, and the treatment of cancer and supportive care, infectious diseases such as HIV, and neurological disorders such as Alzheimer’s disease, Multiple Sclerosis and Opioid use disorder.

 

###

Aphios

Inspired by Nature, Enabled by Science®

© 2026 Aphios Corporation

Contact Us

  • [email protected]
  • (781) 932-6933
  • 87 Main Street, North Reading, MA 01864 USA
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram
  • Tik Tok